Observational studyClinical rheumatology2025
Immature granulocyte percentage: a practical marker of acute ınflammation in pediatric familial mediterranean fever: A retrospective observational case-control study.
Observational study in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The cally index as an indicator of inflammatory burden across clinical phases of familial mediterranean fever.Clinical rheumatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFamilial Mediterranean Fever (FMF) is a monogenic autoinflammatory disease characterized by recurrent febrile attacks and serositis. Despite its clinical severity, especially in pediatric patients, there is no specific biomarker to objectively differentiate between attack and remission periods. This study aimed to evaluate the clinical utility of immature granulocyte percentage (IG%) in predicting FMF attacks and compare it with traditional inflammatory markers.
methodsNinety-six pediatric FMF patients diagnosed according to Tel-Hashomer criteria and 68 age- and sex-matched healthy controls were included. IG%, neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and conventional acute phase reactants (CRP, SAA, fibrinogen) were assessed during both attack and attack-free periods. ROC analysis was performed to determine the diagnostic performance of IG%.
resultsIG%, NLR, PLR, and SII were significantly elevated during attacks compared to both attack-free patients and controls (p < 0.001 for all). IG% showed no significant difference between attack-free patients and controls (p = 0.581), indicating its specificity for acute inflammation. IG% correlated with SAA (r = 0.250, p = 0.014) and platelet count (r = 0.222, p = 0.030). ROC analysis identified an IG% cut-off value of 0.3 with 81.3% sensitivity and 85.4% specificity (AUC = 0.891). For comparison, CRP exhibited the highest diagnostic accuracy (AUC = 0.981), followed by SAA (AUC = 0.963). Although slightly less powerful than these conventional markers, IG% offers unique clinical value due to its rapid availability and cost-effectiveness. IG% levels were unaffected by MEFV mutation subtype.
conclusionIG% is a reliable, rapid, and cost-effective biomarker for distinguishing acute attacks in pediatric FMF. While CRP and SAA demonstrated higher overall diagnostic accuracy, IG% provided greater specificity by normalizing during remission, highlighting its role as a complementary marker. Its independence from genetic variations and availability via routine CBC supports its practical use in clinical monitoring. Key Points • Immature granulocyte percentage (IG%) is a simple biomarker that can be automatically obtained from routine complete blood counts without additional cost or laboratory procedures. • In pediatric Familial Mediterranean Fever (FMF), IG% was significantly elevated during acute attacks but not in attack-free periods, suggesting its specificity for acute inflammation. • ROC analysis demonstrated good diagnostic performance of IG% (AUC = 0.889), while CRP and SAA showed higher AUCs but remained mildly elevated during remission, reducing their specificity. • Compared to conventional markers, IG% provides a rapid, cost-effective, and practical advantage for clinicians, especially in pediatric settings. • IG% may serve as a complementary biomarker in FMF management and has potential applicability across other acute inflammatory conditions.
Indexed as
Identifiers
41003907What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.